Walgreens has been sued by Arkansas Attorney General Leslie Rutledge, and the case was filed earlier this week. In her filing, she claimed that the pharmacy chain company played a big part in making the opioid crisis situation in the state worse.
Rutledge accused Walgreens of rendering a large number of orders for painkillers, and most of them are suspicious. The lawyer said that this is a violation of Arkansas’ Deceptive Trade Practices Act.
The lawsuit against Walgreens
The lawsuit was filed in Pulaski County Court, and it was stated that the pharmacy did not do enough to make sure that the prescriptions are legitimate and not questionable. It was said that because of Walgreens' failure to monitor the orders, large amounts of the regulated drug were distributed in Arkansas, as per Arkansas Democrat Gazelle.
"Walgreens has a legal responsibility to report suspicious orders and suspicious prescriptions," the attorney general said. "By failing to do so they enabled the black market of prescription drugs to increase dramatically, thus leading to more, greater addiction and more lives lost in the state of Arkansas."
As stated in the lawsuit, from 2006 to 2014, Walgreens fulfilled orders of over 142 million dosages of oxycodone and hydrocodone in the state. Rutledge said that this big amount should have alerted the company to the fact that suspicious orders were being placed.
It was added that such quantities that were distributed in Arkansas far exceeded the normal amount that could be consumed for medical legit purposes. “Walgreens failed to report and halt those orders and instead increased the number of pills distributed,” the statement from the suit reads.
With the filing, the state is seeking a directive that will force Walgreens to act responsibly and comply with federal and state laws. It is also seeking appropriate civil penalties for every violation that the company may have committed against the state’s consumer protection laws.
Walgreens denies the allegations
Walgreens refuted the accusations and stated that it never produced or marketed opioids. The company’s spokesperson further told FOX Business that they never sold the said drug to pain clinics, online pharmacies, and 'pill mills' that worsened the opioid crisis.
"Prior to 2014, we delivered opioids only to our own pharmacies, and the only place we ever sold FDA-approved opioid medications was at the pharmacy counter when presented with valid prescriptions written by DEA-licensed physicians for legitimate medical needs," the firm’s spokesperson said.
Finally, he added that the company’s pharmacists always evaluate and take the law into consideration before deciding whether to fill a prescription for controlled substances.


Xiaomi Shares Drop After SU7 Launch as Margin Concerns Weigh on Investors
Elliott Investment Management Takes Multibillion-Dollar Stake in Synopsys
Palantir's Maven AI Earns Pentagon "Program of Record" Status, Reshaping Military AI Strategy
Goldman Sachs Raises Oil Price Forecasts Amid Strait of Hormuz Disruptions
Tesla FSD EU Approval Delayed to April 10 as RDW Completes Final Review
FCC Approves $3.54B Nexstar-Tegna Merger, Waiving Broadcast Ownership Cap
Apple Defies China's Smartphone Slump with Strong Early 2026 Sales
Sinopec Posts 36.8% Net Profit Drop in 2025 Amid Weak Petrochemical Margins and Energy Transition Pressures
Jeff Bezos Eyes $100 Billion Fund to Transform Manufacturing With AI
Super Micro Computer Shares Plunge After Co-Founder Charged in AI Chip Smuggling Case
Goldman Sachs Delays Bank of England Rate Cut Forecast Amid Middle East Inflation Risks
OpenAI's Desktop Superapp: Unifying ChatGPT, Codex, and Browser Tools for Enterprise AI
Air Canada Express Plane Collides with Ground Vehicle at LaGuardia Airport
Elon Musk Announces Terafab: SpaceX and Tesla to Build Dual AI Chip Factories in Austin, Texas
Judge Dismisses Sam Altman Sexual Abuse Lawsuit, But Sister Can Refile
Netflix Eyes South Korea for More Live Events as BTS Concert Livestream Approaches
FEMSA Cuts Jobs at Spin Fintech Unit, Refocuses Strategy on Oxxo Stores 



